Skip to main content
Caplight Logo









Komo Biosciences

Komo Biosciences

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://komobiosciences.com/

Last Round

Seed

Jul 9, 2024

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Komo Biosciences is a biotechnology company that provides a next-generation precision genome engineering technology for the development and manufacturing of therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

genome engineeringgene integrationintegrase technologylarge payload integrationsite-specific integrationcell line developmentgene writingnon-viral gene deliverynon-nuclease genome engineeringlanding pad technologybiologics manufacturingsynthetic biologycell therapygene therapyagricultural biotechnologyCDMOcontract research and development manufacturing organization

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Komo Biosciences Comparables

Compare Komo Biosciences with similar companies based on industry and business-model similarity.

Komo Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IntegraTherapeutics
80%
Stylus Medicine
77%
Prime Medicine
76%

Komo Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 9, 2024

Key People

Founding team and executive leadership

Frank Grazzini

Acting CFO, Co-founder, Acting CFO, Co-founder

Founding Team

Jennifer Manning

Member Board Of Directors, President And Founder CEO

Founding Team

Thomas Page

Chief Technology Officer

Executive Team

Komo Biosciences Investors

Notable investors and investment history

Komo Biosciences investors
InvestorRounds
Genesis BioCapitalSeed
Eshelman VenturesSeed
LDV PartnersSeed
Modi VenturesSeed
General InceptionSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 157% MoM, reaching 493.

  • Nov 8, 2025

    Monthly visitors grew 75% MoM.

Komo Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Komo Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Komo Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range7
Year Founded2024
Last FundingJul 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?